Bruce Schmidt is a graduate of the University of British Columbia with a Bachelor of Science in Physics. He currently operates a private consulting practice in Vancouver focused on technology development within the life-sciences sector. In 1994 he established a new biotechnology company located at the University of BC focused on novel drug therapeutics for cancer and neurological disease. Bruce was one of the Founding Directors of Genome British Columbia in 2000 whose purpose was to bring genomics as an enabling technology to the provincial economy. In 2008, he went on to co-found a new genomics company, GenomeDx, with the objective of enabling personalized medical approaches to chronic disease. He is presently a Director of BioHEP Technologies and the WUTIF Angel Fund and Chairman of CareTeam Inc, all of Vancouver, BC. Bruce has served either currently or in the past as a Director and/or Officer for several public companies listed on the TSX Senior, TSX Venture or Canadian Venture stock exchanges in Canada. Bruce is past-Chairman of both the Life Sciences Industry Association and the Nanotechnology Industry Association in British Columbia. His other community interests include acting as final juror for the New Ventures BC Competition and member of the Private Sector Advisory Committee for Canada's Network Centers of Excellence. In 2009 he founded Intersection Estate Winery in British Columbia's Southern Okanagan Valley.Read less
See Bruce Schmidt at the Extraordinary Future.